550378-39-7 Usage
General Description
(S)-1-Cbz-3-Aminopyrrolidine hydrochloride is a chemical compound with the molecular formula C??H??ClN?O?. It is an amino acid derivative and is commonly used as a key intermediate in organic synthesis. (S)-1-Cbz-3-Aminopyrrolidine hydrochloride is often utilized as a chiral building block for the synthesis of various pharmaceuticals and biologically active compounds. Its hydrochloride form is the salt of the compound that is more stable and water-soluble, making it easier to handle and use in laboratory settings. (S)-1-Cbz-3-Aminopyrrolidine hydrochloride is known for its versatility and is widely utilized in the field of medicinal chemistry and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 550378-39-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,0,3,7 and 8 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 550378-39:
(8*5)+(7*5)+(6*0)+(5*3)+(4*7)+(3*8)+(2*3)+(1*9)=157
157 % 10 = 7
So 550378-39-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H16N2O2.ClH/c13-11-6-7-14(8-11)12(15)16-9-10-4-2-1-3-5-10;/h1-5,11H,6-9,13H2;1H/t11-;/m0./s1
550378-39-7Relevant articles and documents
Discovery of aminopiperidine-based Smac mimetics as IAP antagonists
Hennessy, Edward J.,Saeh, Jamal C.,Sha, Li,MacIntyre, Terry,Wang, Haiyun,Larsen, Nicholas A.,Aquila, Brian M.,Ferguson, Andrew D.,Laing, Naomi M.,Omer, Charles A.
, p. 1690 - 1694 (2012/04/10)
A series of structurally unique Smac mimetics that act as antagonists of inhibitor of apoptosis proteins (IAPs) has been discovered. While most previously described Smac mimetics contain the proline ring (or a similar cyclic motif) found in Smac, a key feature of the compounds described herein is that this ring has been removed. Despite this, compounds in this series potently bind to cIAP1 and elicit the expected phenotype of cIAP1 inhibition in cancer cells. Marked selectivity for cIAP1 over XIAP is observed for these compounds, which is attributed to a slight difference in the binding groove between the two proteins and the resulting steric interactions with the inhibitors. XIAP binding can be improved by constraining the inhibitor so that these unfavorable steric interactions are minimized.